e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Bronchoscopic treatment of emphysema and asthma: what is new?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
QCT analysis of emphysema and air trapping in coil-based lung volume reduction treatment
Youbing Yin (Coralville, United States of America), K. Kontogianni, Y. Yin, M. Schuhmann, P. Raffy, R. Eberhardt, D. Gompelmann, F. Herth
Source:
International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Session:
Bronchoscopic treatment of emphysema and asthma: what is new?
Session type:
Oral Presentation
Number:
1769
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Youbing Yin (Coralville, United States of America), K. Kontogianni, Y. Yin, M. Schuhmann, P. Raffy, R. Eberhardt, D. Gompelmann, F. Herth. QCT analysis of emphysema and air trapping in coil-based lung volume reduction treatment. Eur Respir J 2015; 46: Suppl. 59, 1769
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Quantitative CT (QCT) analysis of emphysema and air trapping in coil-based lung volume reduction (LVRC) treatment
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016
Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
Source: Eur Respir J 2012; 39: 1326-1333
Year: 2012
Densitometry for assessment of effect of lung volume reduction surgery for emphysema
Source: Eur Respir J 2007; 29: 1138-1143
Year: 2007
Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Regional fissure integrity analysis for improved prediction of endobronchial valve lung volume reduction therapy
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015
Comparison of software based CT fissure analyses and endobronchial in-vivo measurements for detection of collateral ventilation for endoscopic lung volume reduction
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema
Source: Eur Respir J 2012; 39: 1084-1089
Year: 2012
Bronchoscopic lung volume reduction
Source: Eur Respir Rev 2006; 15: 99-103
Year: 2006
Endoscopic lung volume reduction (ELVR) in COPD: Changes in lung mechanics with ELVR using the forced oscillation technique (FOT)
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
High resolution computed tomography (HRCT) measurements of lobar volume reduction associated with bronchoscopic thermal vapor ablation (BTVA) in patients with heterogeneous emphysema
Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction
Year: 2011
Lung volume reduction for severe emphysema: do we need a scalpel or a scope?
Source: Eur Respir Rev 2010 19: 242-247
Year: 2010
Endoscopic lung volume reduction (ELVR) in COPD: Improvements in gas transfer capacity correlate with improvements in ventilation and perfusion (VQ) matching
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Volume changes after segmental vapor ablation and associated improvements in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Dynamic hyperinflation after bronchial lung volume reduction: An expected effect or perhaps a preoperative test for selection?
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Reproducibility of airway wall thickness measurements on CT in a lung cancer screening setting
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015
Biologic lung volume reduction therapy for advanced homogeneous emphysema
Source: Eur Respir J 2010; 36: 20-27
Year: 2010
Bronchoscopic lung volume reduction interventions for severe emphysema
Source: International Congress 2016 – Vitamin D and asthma prevention, COPD screening, and bronchoscopic lung volume reduction in emphysema
Year: 2016
Comparison of the lung ventilation assessed by a full-scale airway network flow model and xenon-enhanced dual-energy CT of patients with COPD
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept